Area of research
Pulmonary and Respiratory Medicine · Radiation
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Advanced Radiotherapy Techniques, and Radiopharmaceutical Chemistry and Applications.
A practical framework for operationalising responsible and equitable artificial intelligence in health care: tackling bias, inequity, and implementation challenges
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial
The landscape of N6-methyladenosine in localized primary prostate cancer
Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer − a systematic review and expert consensus
In vivo CRISPR screens identify a dual function of MEN1 in regulating tumor–microenvironment interactions
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial
Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer
The influence of the “cancer” label on perceptions and management decisions for low-grade prostate cancer
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
Low-Grade Prostate Cancer: Time to Stop Calling It Cancer
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
Stereotactic Ablative Radiotherapy for the Management of Spinal Metastases
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
ONECUT2 is a driver of neuroendocrine prostate cancer
048 Canadian TrueNTH Sexual Health and Rehabilitation eClinic (SHAReClinic): Online Education and Support for Prostate Cancer Patients and their Partners
Genomic hallmarks of localized, non-indolent prostate cancer
Spatial genomic heterogeneity within localized, multifocal prostate cancer
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study